The clinical behaviour and mean peak serum aspartate aminotransferase (SGOT) values of 106 patients admitted to a coronary care unit with acute myocardial infarction who displayed acute systolic hypertension were studied. Another 106 normotensive patients with acute myocardial infarction acted as controls. Neither group had established hypertension. The mortality rate, incidence of cardiac failure, major arrhythmias, and mean peak SGOT were significantly greater in the hypertensive group, within which the duration of hypertension was correlated with mean peak SGOT levels-though there was no definite relation between the height of systolic or diastolic pressure and SGOT.
Introduction
Patients with long-standing hypertension who suffer acute myocardial infarction have a relatively poor prognosis compared with those with a previously normal blood pressure.' 2 Some patients, however, enter hospital with acute myocardial infarction and are found to have a raised blood pressure for the first time. This usually resolves without specific treatment and has been considered to reflect catecholamine release from the infarcted area of myocardium combined with sympathetic overactivity as a result of chest pain or anxiety, or both.3' Our study was designed to assess the prognostic significance of acute systolic hypertension in this group of patients.
Patients and Methods
Out of 693 patients admitted with an acute myocardial infarction to the coronary care unit, Kingston General Hospital, Hull, between January 1972 and December 1974 106 patients (87 men and 19 women) had a raised systolic blood pressure on admission without a history of established hypertension (systolic hypertensive group). We defined a raised systolic blood pressure as a pressure of 170 mm Hg or more which persisted for at least 30 minutes. In all patients the blood pressure fell to less than 150 mm Hg within 72 hours. The diastolic blood pressure was considered to be raised when its initial value was 100 mm Hg or more (recorded at the fourth sound of Korotkow). The first 106 patients admitted with acute myocardial infarction from January 1973 with systolic blood pressures between 120-150 mm Hg and diastolic blood pressures less than <100 mm Hg on admission were selected as controls. None Patients with systolic blood pressures between 151-169 mm Hg were excluded since we considered these levels to be "borderline" in this age range. Patients with systolic blood pressures less than 150 mm Hg but with initial diastolic blood pressures of over 100 mm Hg were also excluded because we thought that some of them were likely to be longstanding undetected hypertensive subjects with reduced ("clipped") systolic blood pressures after acute myocardial infarction.
The blood pressure was measured on admission and 30 minutes later. Thereafter recordings were made every four hours for the first 72 hours and then six hourly for the remainder of the patients' stay in hospital unless there was an indication for making more frequent measurements.
The diagnosis of acute anterior and posterior myocardial infarction was based on the electrocardiographic (E.C.G.) criteria of the World Health Organization.5 The recommendations of Perloff were used to define "true" posterior infarction.6 When the site of infarction was obscured by pre-existing E.C.G. abnormalities (previous myocardial infarction or left bundle branch block or both) recent infarction was diagnosed on the basis of a characteristic history, a raised peak serum aspartate aminotransferase (SGOT) level, a typical temperature curve, and a raised sedimentation rate.7 E.C.G.s were performed on each of the first three days of the patients' stay in the coronary care unit and weekly thereafter unless there was an indication for obtaining further records. SGOT was estimated daily for at least the first three days then weekly. Measurements were made by a modified spectrophotometric method using a reaction rate analyser. The SGOT was considered abnormal if 10% above the laboratory's upper limit of normal of 22 IU/1.
The subsequent inpatient progress of both groups was examined to obtain data on (a) the peak SGOT; (b) the incidence of major arrhythmias (ventricular tachycardia, ventricular fibrillation, asystole, and complete heart block), sinus tachycardia (>100 beats/min), and sinus bradycardia (<60 beats/min); (c) the development of left heart failure, defined as radiological pulmonary oedema. Lesser degrees of pulmonary oedema were excluded as observer error here is high; (d) mortality rate; and (e) the presence of glycosuria. Urine was tested routinely in all patients on admission. Where glycosuria was found a glucose tolerance test was performed before discharge from hospital.
In the systolic hypertensive group the duration of hypertension was recorded both from the time of admission and from the onset of the most severe chest pain (estimated time of infarction). (13) The mortality, incidence of major arrhythmias, and, incidence of cardiac failure in the systolic hypertensive group were greater than in the control group (P<0-01, P<0-001, and P<0-001 respectively; see table I ). The clinical progress and mean peak SGOT levels of the 12 patients in the systolic hypertensive group and the six in the control group who were in cardiac failure on admission did not differ significantly from those of their respective groups as a whole.
Glycosuria was found in 24 patients in the systolic hypertensive group and three patients in the control group (P <0001). The glycosuria was transient in 23 patients. Two patients in each group were subsequently found to have diabetic glucose tolerance curves.
The clinical behaviour and peak SGOT levels were similar in patients who displayed either an initial sinus tachycardia (>100/min) or sinus bradycardia (<60/min) in both groups.
At outpatient follow-up 13 Our results support the latter view since the mortality rate and the incidence of major arrhythmias and heart failure were greater in those patients who had initial systolic hypertension. Furthermore, the significantly higher mean peak SGOT level in this group suggests more extensive myocardial damage." " The direct correlation between the duration of systolic hypertension and the mean peak SGOT values also implies increasing myocardial damage in the presence of persistently raised systolic blood pressure. The alternative interpretation-that the rise in blood pressure after acute myocardial infarction is merely an expression of an initially large infarct-would, therefore, seem less likely, especially as the duration of chest pain was similar in both groups.
A raised blood pressure after acute myocardial infarction is usually attributed to increased catecholamine release,4 and this may have accounted for the high incidences of glycosuria and major arrhythmias in our non-diabetic patients. '3 After acute myocardial infarction jeopardized myocardial tissue may be potentially salvageable for several hours if the myocardial oxygen supply is increased or the demand reduced. '4 Several therapeutic programmes have been proposed in an attempt to restrict infarct size, including the use of intravenous p-blockade,"5 nitroglycerin,"' immediate myocardial revascularization,17 and both external and intra-aortic balloon counter pulsation. '8 19 Promising results have also been obtained using hypotensive treatment to reduce myocardial oxygen demands. Kelly et a1.20 showed an apparent haemodynamic benefit from the administration of intravenous phentolamine in five patients with "acute hypertension" after myocardial infarction. They were less optimistic, however, about its use in five of their patients with established hypertension because two developed disproportionate tachycardia and recurrence of chest pain which necessitated discontinuation of hypote'nsive treatment. Similarly, Shell and Sobel'0 using trimetaphan camsylate in a group of 14 hypertensive patients (blood pressure 145/90 mm Hg) showed that cautious reduction of blood pressure after acute myocardial infarction seemed to limit infarct size; 10 of these patients also had established hypertension. In both these studies, however, hypotensive treatment was delayed for a mean of nine and 11 hours respectively after the onset of acute symptoms. In the light of these previous reports our observations suggest Twenty women had primary amenorrhoea. Gonadal dysgenesis confirmed by gynaecography or laparoscopy was present in five of these, two of whom showed chromosomal abnormalities. Laparoscopy in seven of the remaining 15 patients showed small ovaries but biopsy showed plentiful follicular tissue in five women.
Of the other 36 amenorrhoeic patients six presented with menopausal symptoms suggesting premature ovarian failure; no follicles were seen in ovarian biopsies from four, and in the other two, though occasional follicles were observed, there was no change in urinary oestrogen levels after large doses of human menopausal gonadotrophins. Amenorrhoea occurred after stopping oral contraception in seven women, after a miscarriage in one, and after delivery in one. The onset of amenorrhoea was associated with weight loss in 11 women, five of whom were considered to have anorexia nervosa; emotional factors were implicated in four other women. One woman had chronic liver disease with sclerocystic ovaries found at laparoscopy, and one suffered from intestinal malabsorption. No clear cause was apparent in the remaining four women. Of the 14 
